← Back to Search

Lifestyle Intervention for Cardiovascular Disease

N/A
Waitlist Available
Led By David S Drozek, DO
Research Sponsored by Ohio University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up yearly for 10 years
Awards & highlights

Summary

The purpose of this study is to evaluate the change in disease prevalence over time in impoverished urban communities in Lima, Peru.

Eligible Conditions
  • Cardiovascular Disease
  • Dyslipidemia
  • Diabetes
  • High Blood Pressure
  • Obesity

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~yearly for 10 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and yearly for 10 years for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Diastolic Blood Pressure
High density lipoprotein cholesterol
Low-density lipoprotein cholesterol
+5 more
Secondary study objectives
24 hour dietary recall
Exercise vital sign
Herth Hope Index
+3 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Lifestyle InterventionExperimental Treatment1 Intervention
Impoverished communities in Lima, Peru will be offered free medical clinics. Four communities have been chosen initially for focus over the following 10 years. These communities will be made aware of their risk for chronic lifestyle related diseases. In conjunction with the communities, specific interventions focused on a plant-based diet, physical activity, stress management and control of unhealthy habits will be devised.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Lifestyle Modification
2006
Completed Phase 4
~2280

Find a Location

Who is running the clinical trial?

Ohio UniversityLead Sponsor
71 Previous Clinical Trials
36,350 Total Patients Enrolled
David S Drozek, DOPrincipal InvestigatorOhio University
5 Previous Clinical Trials
987 Total Patients Enrolled
~104 spots leftby Sep 2025